UConn Health
Technology Incubation Program Building
Grossman Auditorium
400 Farmington Ave.
Farmington, CT 06032
The mission of Technology Commercialization Services is to expedite and facilitate the transformation of UConn discoveries into products and services that benefit society.
Our goals are to bring together UConn researchers and the business community in order to significantly enhance the commercial and societal impact of UConn’s research; identify and help move inventions by UConn faculty, staff and students towards the market through licensing, or new company formation; secure patent protection for new technologies, where warranted by market forces; generate industrial support for ongoing applied/translational research projects.
Contact us to evaluate and protect a UConn invention; find proof of concept and/or startup funding at UConn, from the investment community, as well as state and private sources; receive coaching and mentoring for your new venture; start a company; license a technology; incubate your business at UConn; access University-wide programs supporting innovation and entrepreneurship.
For more information, please visit: http://research.uconn.edu/technology-commercialization
Luck is where preparation meets opportunity.
In this unique seminar, an in-licensing officer from Novo Nordisk and patent attorneys from Hamilton Brook Smith Reynolds will present topics to increase your understanding of what industry wants and the patent system requires to position your innovation for successful commercialization. UConn’s Technology Commercialization Services will describe its role in facilitating that success.
Key topics:
The presentation will be followed by Q & A and
a networking lunch in the Cafe.
Aaron Schwartz
Director, Search & Evaluation, Global Drug Discovery
Novo Nordisk
Deirdre E. Sanders
Principal Attorney, Life Sciences
Hamilton Brook Smith Reynolds
Deirdre has 20+ years of experience in strategic biotechnology patent prosecution counseling and in intellectual property litigation and enforcement. She is dedicated to guiding clients through the development, management, and protection of intellectual property rights to achieve their business goals. Deirdre’s patent practice is focused in the field of biotechnology with a particular emphasis in the areas of biologics including antibody-based therapeutics, pharmaceuticals, immuno-oncology and immunotherapy, vaccines, microbiomes, bioinformatics, protein-based sensors, and drug discovery and development.
Mark B. Solomon
Principal Attorney, Engineering
Hamilton Brook Smith Reynolds
Mark’s 20 years in patent law complements his 10 years as an electrical and control systems engineer, which he uses in guiding companies and universities through the development, management, protection, and enforcement of intellectual property rights. He provides high value IP services for clients who value IP by drafting and prosecuting patent applications from strategic business or licensing perspectives. Mark’s technical background includes diverse engineering technologies, such as motion control systems, process control systems, medical devices, mechanical devices, robotics, autonomous vehicles, telecommunications, optics and opto-electronics, signal processing, image processing, voice processing, optical networking and electrical networking, business methods, analog electronics and digital electronics, software, GPS systems, antennas, mobile devices, nano-materials, semiconductors, fuel cells and other renewable energy systems, artificial intelligence such as neural networks, and the Internet-of-Things.